These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12727849

  • 1. Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.
    Fedorov LM, Papadopoulos T, Tyrsin OY, Twardzik T, Götz R, Rapp UR.
    Cancer Res; 2003 May 01; 63(9):2268-77. PubMed ID: 12727849
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The differential effects of mutant p53 alleles on advanced murine lung cancer.
    Jackson EL, Olive KP, Tuveson DA, Bronson R, Crowley D, Brown M, Jacks T.
    Cancer Res; 2005 Nov 15; 65(22):10280-8. PubMed ID: 16288016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y, Zhang Z, Lubet RA, You M.
    Oncogene; 2006 Feb 23; 25(8):1277-80. PubMed ID: 16247444
    [Abstract] [Full Text] [Related]

  • 7. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM.
    Oncogene; 2000 Nov 09; 19(47):5338-47. PubMed ID: 11103935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf.
    Fedorov LM, Tyrsin OY, Papadopoulos T, Camarero G, Götz R, Rapp UR.
    Cancer Res; 2002 Nov 01; 62(21):6297-303. PubMed ID: 12414660
    [Abstract] [Full Text] [Related]

  • 11. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma.
    Hammoud Z, Tan B, Badve S, Bigsby RM.
    Endocr Relat Cancer; 2008 Jun 01; 15(2):475-83. PubMed ID: 18509000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers.
    Chatterji B, Borlak J.
    Proteomics; 2007 Nov 01; 7(21):3980-91. PubMed ID: 17902193
    [Abstract] [Full Text] [Related]

  • 17. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
    Götz R, Kramer BW, Camarero G, Rapp UR.
    BMC Cancer; 2004 Nov 24; 4():85. PubMed ID: 15560850
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.